A comparison of glycaemic and metabolic control over time among South Asian and European patients with Type 2 diabetes: results from follow-up in a routine diabetes clinic

被引:77
作者
Mukhopadhyay, B
Forouhi, NG
Fisher, BM
Kesson, CM
Sattar, N
机构
[1] Glasgow Royal Infirm, Dept Diabet, Glasgow, Lanark, Scotland
[2] MRC, Epidemiol Unit, Cambridge, England
[3] Victoria Infirm, Dept Diabet, Glasgow, Lanark, Scotland
[4] Univ Glasgow, Glasgow, Lanark, Scotland
基金
英国医学研究理事会;
关键词
ethnicity; obesity; insulin resistance; lipids; blood pressure;
D O I
10.1111/j.1464-5491.2005.01735.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Although South Asians have a higher prevalence of diabetes which develops at a younger age, data on change in metabolic parameters post-diagnosis are relatively sparse. We therefore wished to determine whether South Asians with diabetes had similar or greater year-on-year deterioration in metabolic parameters compared with Europeans. Methods We analysed longitudinal change in metabolic parameters [glycated haemoglobin (HbA(1c)), blood pressure, body mass index (BMI), lipids] among South Asian (n = 210) and European (n = 1557) patients consecutively attending the same diabetes clinic over a mean period of 5.3 years. Resulst South Asians were younger than Europeans at first recorded diagnosis of diabetes (mean age 45.9 vs. 57.3 years, P < 0.001) and had significantly lower (similar to 1.2 units) BMI and blood pressure. Mean HbA(1c) was not different across ethnic groups at first visit, but with time glycaemic control was worse in South Asians than Europeans, with average deterioration 1.31% (= 0.23%/year) in Asians vs. 0.82% (0.16%/year) in Europeans, P = 0.003. This ethnic difference in mean change in HbA(1c) persisted after adjustment for age, sex, baseline HbA(1c), and weight change in linear regression analysis (beta = 0.46, 95% CI 0.24-0.69, P < 0.001), and with additional adjustment for time to referral and duration of diabetes (P = 0.01). Moreover, South Asians had significantly smaller improvements in blood pressure (P < 0.001) and cholesterol (P = 0.044) over the follow-up period in keeping with fewer prescriptions of anti-hypertensive agents and lipid-lowering agents. Conclusions These data suggest the need to be more aggressive in the management of diabetes and related risk factors in South Asians.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 15 条
[1]   Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men [J].
Abate, N ;
Chandalia, M ;
Snell, PG ;
Grundy, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2750-2755
[2]  
Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3
[3]   Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients [J].
Barnett, AH ;
Grant, PJ ;
Hitman, GA ;
Mather, H ;
Pawa, M ;
Robertson, L ;
Trelfa, A .
DIABETIC MEDICINE, 2003, 20 (05) :387-393
[4]   INCREASED INCIDENCE OF END-STAGE RENAL-FAILURE SECONDARY TO DIABETES-MELLITUS IN ASIAN ETHNIC-GROUPS IN THE UNITED-KINGDOM [J].
BURDEN, AC ;
MCNALLY, PG ;
FEEHALLY, J ;
WALLS, J .
DIABETIC MEDICINE, 1992, 9 (07) :641-645
[5]   Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes - UK prospective diabetes study (UKPDS 55) [J].
Davis, TME ;
Cull, CA ;
Holman, RR .
DIABETES CARE, 2001, 24 (07) :1167-1174
[6]   Ethnicity and renal disease: questions and challenges [J].
Feehally, J .
CLINICAL MEDICINE, 2003, 3 (06) :578-582
[7]   Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men [J].
Forouhi, NG ;
Jenkinson, G ;
Thomas, EL ;
Mullick, S ;
Mierisova, S ;
Bhonsle, U ;
McKeigue, PM ;
Bell, JD .
DIABETOLOGIA, 1999, 42 (08) :932-935
[8]   Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians [J].
Forouhi, NG ;
Sattar, N ;
McKeigue, PM .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (09) :1327-1331
[9]  
FOROUHI NG, 2000, THESIS LONDON U LOND
[10]  
Mather HM, 1998, DIABETIC MED, V15, P53, DOI 10.1002/(SICI)1096-9136(199801)15:1<53::AID-DIA521>3.0.CO